APOZEAL PHARMA, a USA based, newly formed pharmaceutical manufacturing, research and development company has acquired Torrent Pharma facility and products based in Levittown Pennsylvania, USA for an undisclosed sum.

Established in 1992, this site has a proven track record in the research & development and manufacturing of oral solutions, suspensions, and suppositories. It's 75,000 sq. ft US FDA registered facility also has DEA approved manufacturing capabilities for controlled substances (DEA Schedule II-V). Apozeal Pharma has acquired 10 approved ANDAs, many ANDAs filed and under review at the US FDA and additional ANDA products under development under this deal.

Apozeal plans to revamp the facility to cGMP standards and start commercial manufacturing, packaging, warehouse, sales and distribution, research & development operations from this site as soon as possible to be able to fully realize the potential of the site. Apozeal Pharma plans to manufacture 100% of drug product in USA and also has plans to diversify in other pharmaceutical dosage forms i.e. solid orals and injectables in the future.